Developer docs
API playgroundTry for free, no card

Search company profiles

The FDA Group

Full company profile

uuid000a3w1

Namestring
The FDA Group
Legal namestring
The FDA Group, LLC
Websiteurl
thefdagroup.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

The FDA Group is a privately held, Massachusetts-based life science consulting and staffing firm founded in 2007 that serves FDA-regulated industries including pharmaceutical, biologic, and medical device manufacturers. The company operates two complementary engagement models: project-based consulting engagements and contracted full-time staff augmentation, supplying subject matter experts across quality assurance, regulatory affairs, clinical operations, validation, and remediation functions. Its service catalog spans GxP audits and mock FDA inspections, regulatory submissions (IND, 510(k), ANDA, 505(b)(2)), Form 483 and warning letter remediation, quality management system development, and specialized support for QMSR transition, data integrity, and EU MDR/IVDR compliance.

The firm's core operational asset is a proprietary network of 3,750+ consultants spanning 75+ countries, including 325+ former FDA personnel, paired with a documented matching process that claims 95% first-time right-resource placement and 97% client satisfaction. In March 2026, the company commercially launched AICA (Audit Intelligence Compliance Assistant), a patent-pending, AI-powered compliance auditing platform that analyzes 100% of QMS documentation against 21 CFR Parts 11, 211, and 600. AICA is built on EPAM Systems' DIAL Open-Source GenAI Enterprise Platform and hosted on Microsoft Azure in the United States, with training supervision provided by 15+ in-house regulatory professionals.

Revenue is generated primarily through project-based and contracted consulting engagements sold via enterprise field sales to top-tier life science organizations, complemented by a subscription Insider Newsletter ($9.99-$29.99/month) and content/media assets (The Life Science Rundown podcast). Customer logos include Johnson & Johnson, Pfizer, Merck, Eli Lilly, Novo Nordisk, Sanofi, Bayer, Abbott, Medtronic, Stryker, Philips, Thermo Fisher Scientific, Regeneron, Takeda, and Fujifilm, with the company claiming penetration of 17 of the top 25 largest life science companies and 17 of the top 20 life science firms for remediation and consulting services respectively.

Short descriptiontext

The FDA Group is a privately held life science consulting and staffing firm, founded in 2007, that supplies former-FDA and industry subject matter experts to pharmaceutical, biologic, and medical device manufacturers for QA, regulatory affairs, audits, remediation, and AI-enabled compliance work.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory consulting services, life science staffing, FDA compliance auditing, quality assurance consulting, pharmaceutical regulatory affairs
Product category
Regulatory Consulting Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Staff Augmentation & Consulting
TypeProfessional Services
Description

Providing contracted subject matter experts including former FDA and industry professionals for quality assurance, regulatory affairs, and clinical operations. Revenue generated through hourly/daily rates for contracted consultants placed with clients for project-based or ongoing engagements.

thefdagroup.com
2Compliance Auditing Services
TypeProfessional Services
Description

AICA platform for AI-powered QMS documentation auditing. Services include GMP, GLP, GCP audits, mock FDA inspections, gap assessments, and specialized compliance reviews.

thefdagroup.com
3Regulatory Submissions
TypeProfessional Services
Description

Support for drug and medical device regulatory submissions including IND applications, 510(k) filings, 505(b)(2) and ANDA submissions, FDA meeting preparation.

thefdagroup.com
4Remediation Services
TypeProfessional Services
Description

Quality system remediation, Form 483 response, warning letter response, data integrity remediation, and facility compliance remediation services.

thefdagroup.com
5Insider Newsletter Subscription
TypeSubscription Recurring
Description

Premium monthly newsletter delivering regulatory and compliance analysis from former FDA staff. Includes video content, transcripts, and exclusive resources. Billed at $29.99/month or promotional rates.

thefdagroup.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details3 tiers
1Insider Newsletter - Monthly Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

$29.99/month for premium newsletter with regulatory analysis, video content, and exclusive resources

thefdagroup.com
2Insider Newsletter - Annual Subscription with 50% discount
ModelSubscriptionBilling cadenceAnnual
Notes

$9.99/month ($119.88/year) with 50% discount promotional offer

insider.thefdagroup.com
3Consulting & Staff Augmentation Services
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing. Rates vary by consultant expertise level (e.g., former FDA officials command premium rates), engagement duration, and project complexity. Project-based consulting engagements and contracted full-time consultant staffing supported.

thefdagroup.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1AICA
Description

Audit Intelligence Compliance Assistant - An AI-powered compliance auditing platform for pharmaceutical and biologic companies. Trained by 15+ regulatory professionals on real QMS documentation, it analyzes policies and procedures against FDA regulations to identify gaps in minutes or hours instead of days or weeks.

thefdagroup.com
Core offering1 text field

No source-backed description is available. The input contained a planning note without attributable source IDs, so the core offering cannot be extracted.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% success rate in placing right resource first time
+3 more records
Product overview1 text field

The FDA Group offers a portfolio of consulting services and technology products for FDA-regulated life science industries. The core product is AICA (Audit Intelligence Compliance Assistant), an AI-powered compliance auditing platform launched in March 2026, complemented by staff augmentation, regulatory submissions, audits/mock inspections, remediation services, and QMS consulting. The company also offers subscription content products including the Insider Newsletter and The Life Science Rundown podcast. The service model is primarily consulting-based (contracted subject matter experts), with AICA representing the company's first AI-powered software product.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1EPAM Systems, Inc.
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-19
Description

Strategic technology partnership for development of AICA (Audit Intelligence Compliance Assistant). EPAM contributed its DIAL Open-Source GenAI Enterprise Platform to build the AI-powered compliance auditing tool. The platform analyzes QMS documentation against FDA regulations, developed with expertise from 15+ regulatory professionals.

epam.com
2Microsoft Azure
Strategic tierCoreTypeTechnology or Integration
Description

Cloud infrastructure partner hosting AICA platform in the United States. Microsoft Azure provides the cloud environment for the AI-powered compliance auditing tool.

einpresswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ICON plc is a global CRO providing clinical, regulatory, and laboratory services with deep pharma/biotech relationships. Broad incumbent competing for similar regulatory and quality consulting engagements at large life science clients.

TypeDirect peer
Description

Validant is a regulatory and compliance consulting firm exclusively focused on the pharmaceutical, biotechnology, and medical device industries. Direct peer offering RA/QA consulting, remediation, and quality system services to FDA-regulated clients.

TypeRegional player
Description

MakroCare is a global clinical research and regulatory consulting firm with strong presence in India, Europe, and Asia. Comparable peer providing regulatory and clinical services to pharma and biotech, with significant overlap in regulatory affairs and quality consulting offerings.

TypeBroad incumbent
Description

Parexel is a global CRO and biopharmaceutical services firm offering clinical, regulatory, and consulting services. Broad incumbent with overlapping regulatory affairs and compliance consulting capabilities serving the same pharma/biotech client base.

TypeDirect peer
Description

ProPharma Group is a life sciences consulting and regulatory affairs services firm providing compliance, regulatory, and quality assurance support to pharma/biologic manufacturers. Highly comparable direct peer in FDA-regulated consulting and RA/QA staffing.

TypeBroad incumbent
Description

IQVIA is the world's largest life sciences services provider spanning clinical research, real-world evidence, and regulatory/quality consulting. Broad incumbent that competes with The FDA Group for enterprise pharma and device consulting and staffing engagements.

TypeEmerging player
Description

Veeva Systems provides cloud-based life sciences software including quality, regulatory, and compliance solutions. Closest software competitor to The FDA Group's AICA platform, offering regulated QMS and document/compliance tooling to overlapping pharma/biologic customers.

TypeEmerging player
Description

MasterControl provides quality management software (eQMS) for life sciences and regulated manufacturers. Software comparator to AICA's AI compliance auditing, with overlapping GxP-focused customer base in pharma and medical device.

TypeDirect peer
Description

Greenleaf Health is an FDA regulatory consulting firm staffed by former senior FDA officials. Direct peer leveraging ex-FDA talent to advise pharma, biologic, and device companies on regulatory strategy and compliance.

TypeDirect peer
Description

Lachman Consultant Services provides regulatory affairs, compliance, and quality assurance consulting to the pharmaceutical and life sciences industries. Direct peer offering GMP, GLP, validation, and remediation services to FDA-regulated manufacturers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The FDA Group

Regulatory Consulting Servicesthefdagroup.com

The FDA Group is a privately held life science consulting and staffing firm, founded in 2007, that supplies former-FDA and industry subject matter experts to pharmaceutical, biologic, and medical device manufacturers for QA, regulatory affairs, audits, remediation, and AI-enabled compliance work.

What The FDA Group does

The FDA Group is a privately held, Massachusetts-based life science consulting and staffing firm founded in 2007 that serves FDA-regulated industries including pharmaceutical, biologic, and medical device manufacturers. The company operates two complementary engagement models: project-based consulting engagements and contracted full-time staff augmentation, supplying subject matter experts across quality assurance, regulatory affairs, clinical operations, validation, and remediation functions. Its service catalog spans GxP audits and mock FDA inspections, regulatory submissions (IND, 510(k), ANDA, 505(b)(2)), Form 483 and warning letter remediation, quality management system development, and specialized support for QMSR transition, data integrity, and EU MDR/IVDR compliance.

The firm's core operational asset is a proprietary network of 3,750+ consultants spanning 75+ countries, including 325+ former FDA personnel, paired with a documented matching process that claims 95% first-time right-resource placement and 97% client satisfaction. In March 2026, the company commercially launched AICA (Audit Intelligence Compliance Assistant), a patent-pending, AI-powered compliance auditing platform that analyzes 100% of QMS documentation against 21 CFR Parts 11, 211, and 600. AICA is built on EPAM Systems' DIAL Open-Source GenAI Enterprise Platform and hosted on Microsoft Azure in the United States, with training supervision provided by 15+ in-house regulatory professionals.

Revenue is generated primarily through project-based and contracted consulting engagements sold via enterprise field sales to top-tier life science organizations, complemented by a subscription Insider Newsletter ($9.99-$29.99/month) and content/media assets (The Life Science Rundown podcast). Customer logos include Johnson & Johnson, Pfizer, Merck, Eli Lilly, Novo Nordisk, Sanofi, Bayer, Abbott, Medtronic, Stryker, Philips, Thermo Fisher Scientific, Regeneron, Takeda, and Fujifilm, with the company claiming penetration of 17 of the top 25 largest life science companies and 17 of the top 20 life science firms for remediation and consulting services respectively.

The FDA Group firmographics

Firmographics
Name
The FDA Group
Legal name
The FDA Group, LLC
Website
https://thefdagroup.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Short description
The FDA Group is a privately held life science consulting and staffing firm, founded in 2007, that supplies former-FDA and industry subject matter experts to pharmaceutical, biologic, and medical device manufacturers for QA, regulatory affairs, audits, remediation, and AI-enabled compliance work.
Ownership category
akta.pro rank

Where The FDA Group is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The FDA Group business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Staff Augmentation & Consulting: Providing contracted subject matter experts including former FDA and industry professionals for quality assurance, regulatory affairs, and clinical operations. Revenue generated through hourly/daily rates for contracted consultants placed with clients for project-based or ongoing engagements.
  2. Compliance Auditing Services: AICA platform for AI-powered QMS documentation auditing. Services include GMP, GLP, GCP audits, mock FDA inspections, gap assessments, and specialized compliance reviews.
  3. Regulatory Submissions: Support for drug and medical device regulatory submissions including IND applications, 510(k) filings, 505(b)(2) and ANDA submissions, FDA meeting preparation.
  4. Remediation Services: Quality system remediation, Form 483 response, warning letter response, data integrity remediation, and facility compliance remediation services.
  5. Insider Newsletter Subscription: Premium monthly newsletter delivering regulatory and compliance analysis from former FDA staff. Includes video content, transcripts, and exclusive resources. Billed at $29.99/month or promotional rates.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyInsider Newsletter - Monthly Subscription
SubscriptionAnnualInsider Newsletter - Annual Subscription with 50% discount
OtherMulti-year contractConsulting & Staff Augmentation Services

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

The FDA Group product offering

Product offering

Core offering

No source-backed description is available. The input contained a planning note without attributable source IDs, so the core offering cannot be extracted.

Product overview

The FDA Group offers a portfolio of consulting services and technology products for FDA-regulated life science industries. The core product is AICA (Audit Intelligence Compliance Assistant), an AI-powered compliance auditing platform launched in March 2026, complemented by staff augmentation, regulatory submissions, audits/mock inspections, remediation services, and QMS consulting. The company also offers subscription content products including the Insider Newsletter and The Life Science Rundown podcast. The service model is primarily consulting-based (contracted subject matter experts), with AICA representing the company's first AI-powered software product.

Differentiator

Problem solved

Functional benefit

Brands

  • AICA: Audit Intelligence Compliance Assistant - An AI-powered compliance auditing platform for pharmaceutical and biologic companies. Trained by 15+ regulatory professionals on real QMS documentation, it analyzes policies and procedures against FDA regulations to identify gaps in minutes or hours instead of days or weeks.

Quantifiable outcome

  • 95% success rate in placing right resource first time
  • +3 more outcomes

Companies that use The FDA Group

Customer profile

Named customers16 records

Segments5 records

Ideal customer profiles1 record

The FDA Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

The FDA Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • EPAM Systems, Inc.coreTechnology or Integration · 19 March 2026Strategic technology partnership for development of AICA (Audit Intelligence Compliance Assistant). EPAM contributed its DIAL Open-Source GenAI Enterprise Platform to build the AI-powered compliance auditing tool. The platform analyzes QMS documentation against FDA regulations, developed with expertise from 15+ regulatory professionals.
  • Microsoft AzurecoreTechnology or IntegrationCloud infrastructure partner hosting AICA platform in the United States. Microsoft Azure provides the cloud environment for the AI-powered compliance auditing tool.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

The FDA Group competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: ICON plc is a global CRO providing clinical, regulatory, and laboratory services with deep pharma/biotech relationships. Broad incumbent competing for similar regulatory and quality consulting engagements at large life science clients.
  • Parexel International: Parexel is a global CRO and biopharmaceutical services firm offering clinical, regulatory, and consulting services. Broad incumbent with overlapping regulatory affairs and compliance consulting capabilities serving the same pharma/biotech client base.
  • IQVIA: IQVIA is the world's largest life sciences services provider spanning clinical research, real-world evidence, and regulatory/quality consulting. Broad incumbent that competes with The FDA Group for enterprise pharma and device consulting and staffing engagements.

Direct peers

  • Validant: Validant is a regulatory and compliance consulting firm exclusively focused on the pharmaceutical, biotechnology, and medical device industries. Direct peer offering RA/QA consulting, remediation, and quality system services to FDA-regulated clients.
  • ProPharma Group: ProPharma Group is a life sciences consulting and regulatory affairs services firm providing compliance, regulatory, and quality assurance support to pharma/biologic manufacturers. Highly comparable direct peer in FDA-regulated consulting and RA/QA staffing.
  • Greenleaf Health: Greenleaf Health is an FDA regulatory consulting firm staffed by former senior FDA officials. Direct peer leveraging ex-FDA talent to advise pharma, biologic, and device companies on regulatory strategy and compliance.
  • Lachman Consultant Services: Lachman Consultant Services provides regulatory affairs, compliance, and quality assurance consulting to the pharmaceutical and life sciences industries. Direct peer offering GMP, GLP, validation, and remediation services to FDA-regulated manufacturers.

Regional players

  • MakroCare: MakroCare is a global clinical research and regulatory consulting firm with strong presence in India, Europe, and Asia. Comparable peer providing regulatory and clinical services to pharma and biotech, with significant overlap in regulatory affairs and quality consulting offerings.

Emerging players

  • Veeva Systems: Veeva Systems provides cloud-based life sciences software including quality, regulatory, and compliance solutions. Closest software competitor to The FDA Group's AICA platform, offering regulated QMS and document/compliance tooling to overlapping pharma/biologic customers.
  • MasterControl: MasterControl provides quality management software (eQMS) for life sciences and regulated manufacturers. Software comparator to AICA's AI compliance auditing, with overlapping GxP-focused customer base in pharma and medical device.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

The FDA Group social profiles

Digital presence

The FDA Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The FDA Group leadership team

Management profile

Number of profiles

The FDA Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The FDA Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The FDA Group

What does The FDA Group do?

No source-backed description is available. The input contained a planning note without attributable source IDs, so the core offering cannot be extracted.

Is The FDA Group a public or private company?

The FDA Group is a private company. It is classified as unknown and is currently operating.

When was The FDA Group founded?

The FDA Group was founded in 2007. It employs 51 to 100 people.

Where is The FDA Group based?

The FDA Group is headquartered in Boston, United States, in the North America region.

How does The FDA Group make money?

Five revenue lines are on record. Staff Augmentation & Consulting is the primary driver. The others are compliance Auditing Services, regulatory Submissions, remediation Services and insider Newsletter Subscription.

Who are The FDA Group's main competitors?

Broad incumbents on record are ICON plc, Parexel International and IQVIA. Direct peers are Validant, ProPharma Group, Greenleaf Health and Lachman Consultant Services. MakroCare is listed as a regional player. Emerging players are Veeva Systems and MasterControl.

Does The FDA Group have an API?

No public API is recorded for The FDA Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IntuitionLabsFDA Compliance Monitoring: A Guide to Top Software & ServicesA comprehensive market report surveys the FDA compliance monitoring landscape as enforcement intensifies, with the agency issuing approximately 470 warning letters across all centers in calendar year 2025 and CDER warning letters jumping 50% over FY2024, while the new Quality Management System Regulation (QMSR) took effect February 2, 2026, replacing 21 CFR Part 820 with ISO 13485 standards. The report profiles ten leading compliance providers spanning both software platforms (MasterControl, Sparta Systems/TrackWise, Veeva Vault, ComplianceQuest, Greenlight Guru, and Qualio) and consulting firms (EAS Consulting Group, The FDA Group, ProPharma Group, and Emergo by UL), covering their services, market positions, and client bases. The global QMS software market was valued at $12.5 billion in 2025 and is projected to reach $20.7 billion by 2030, driven by regulatory pressures, digital transformation, and the adoption of AI-enabled compliance analytics.EPAMAI-Powered Life Sciences Compliance Auditing PlatformThe FDA Group announced the commercial launch of AICA (Audit Intelligence Compliance Assistant), an AI-powered platform for pharmaceutical and biologic compliance auditing developed in collaboration with EPAM Systems, Inc. The platform analyzes 100% of QMS documentation in hours rather than the days or weeks required for manual audits, addressing a long-standing operational challenge in regulated industries. AICA is built on EPAM's DIAL Open-Source GenAI Enterprise Platform and hosted on Microsoft Azure in the United States.Progress-indexThe FDA Group Launches AICA, an AI-Powered Compliance Auditing Platform Purpose-Built for Life SciencesThe FDA Group has launched AICA (Audit Intelligence Compliance Assistant), an AI-powered compliance auditing platform for pharmaceutical and biologic companies. Developed in collaboration with EPAM Systems, the platform analyzes 100% of QMS documentation against FDA regulations and delivers results in hours rather than the days or weeks required by traditional manual audits. AICA is now commercially available and currently supports auditing against 21 CFR Parts 11, 211, and 600.EIN PresswireThe FDA Group Launches AICA, an AI-Powered Compliance Auditing Platform Purpose-Built for Life SciencesThe FDA Group announced the commercial launch of AICA (Audit Intelligence Compliance Assistant), an AI-powered platform for pharmaceutical and biologic compliance auditing, developed in collaboration with EPAM Systems. The platform analyzes 100% of QMS documentation against FDA regulations and delivers comprehensive gap analysis in hours rather than the days or weeks required for manual audits. AICA is built on EPAM DIAL Open-Source GenAI Enterprise Platform, hosted on Microsoft Azure in the United States, and supports auditing against 21 CFR Parts 11, 211, and 600.ThefdagroupGMP Auditing ServicesThe FDA Group is a specialized consulting firm that provides Good Manufacturing Practice (GMP) auditing, mock inspection, and regulatory compliance services to pharmaceutical, medical device, and biologics manufacturers. The company leverages its team of former FDA investigators and industry experts to help clients achieve inspection readiness and remediate quality system deficiencies.ThefdagroupQuality Management in Cell and Gene Therapy: An Expert Guide (2024)The FDA Group published an expert guide featuring Rafael Torres on quality management challenges in cell and gene therapy, covering workforce retention, regulatory compliance, and manufacturing scalability. The article provides strategic advice for navigating complex supply chains, contamination control, and scaling processes while maintaining cGMP standards.ThefdagroupComputer System Validation (CSV) in the FDA-Regulated IndustriesA guide published by The FDA Group, based on a discussion with consultant Rashida Ray, outlines Computer System Validation (CSV) requirements for FDA-regulated industries, including planning, documentation, risk assessment, data integrity, change control, training and periodic review. It cites 21 CFR Part 11 and recommends process mapping, cross-functional communication, external training and gap assessments.ThefdagroupRegulatory Affairs Consulting ServicesThe FDA Group offers regulatory affairs consulting services, leveraging a staff of former FDA and industry experts to assist clients with complex regulatory challenges. The firm provides support in areas such as regulatory submissions, Chemistry, Manufacturing, and Controls (CMC), and EU MDR/IVDR compliance through various engagement models including consulting projects and staff augmentation.